Imperva Inc (NYSE:IMPV)‘s stock had its “hold” rating reiterated by equities research analysts at Stifel Nicolaus in a research report issued to clients and investors on Thursday. They presently have a $47.00 price objective on the software maker’s stock, down from their prior price objective of $50.00. Stifel Nicolaus’ target price suggests a potential upside of 14.08% from the company’s current price.

Several other research firms have also commented on IMPV. Evercore ISI set a $56.00 price target on shares of Imperva and gave the company a “buy” rating in a research report on Friday, July 28th. Zacks Investment Research raised shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 price target for the company in a research report on Tuesday, October 24th. BidaskClub lowered shares of Imperva from a “hold” rating to a “sell” rating in a research report on Saturday, August 5th. Wells Fargo & Company lowered shares of Imperva from an “outperform” rating to a “market perform” rating in a research report on Monday, October 9th. Finally, Imperial Capital reduced their price target on shares of Imperva from $57.00 to $50.00 and set an “outperform” rating for the company in a research report on Tuesday, October 10th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Hold” and an average target price of $52.38.

Shares of Imperva (NYSE:IMPV) traded up $0.60 during trading hours on Thursday, reaching $41.20. The company’s stock had a trading volume of 222,500 shares, compared to its average volume of 448,881. Imperva has a fifty-two week low of $35.45 and a fifty-two week high of $52.40.

Imperva (NYSE:IMPV) last issued its earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.11. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The business had revenue of $83.89 million during the quarter, compared to analyst estimates of $83.79 million. During the same quarter in the previous year, the firm earned $0.08 EPS. Imperva’s revenue was up 22.6% on a year-over-year basis.

COPYRIGHT VIOLATION WARNING: This story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.watchlistnews.com/imperva-inc-impv-rating-reiterated-by-stifel-nicolaus/1696624.html.

In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the transaction, the director now directly owns 99,598 shares in the company, valued at approximately $4,341,476.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.20% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Imperva by 4.3% during the 2nd quarter. Vanguard Group Inc. now owns 2,439,240 shares of the software maker’s stock valued at $116,718,000 after buying an additional 99,799 shares during the period. BlackRock Inc. raised its holdings in Imperva by 11.3% during the 2nd quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock valued at $101,635,000 after buying an additional 215,170 shares during the period. Eagle Asset Management Inc. raised its holdings in Imperva by 1.2% during the 3rd quarter. Eagle Asset Management Inc. now owns 1,294,651 shares of the software maker’s stock valued at $55,928,000 after buying an additional 14,803 shares during the period. ETF Managers Group LLC purchased a new stake in Imperva during the 2nd quarter valued at $41,888,000. Finally, Emerald Advisers Inc. PA raised its holdings in Imperva by 15.8% during the 3rd quarter. Emerald Advisers Inc. PA now owns 657,005 shares of the software maker’s stock valued at $28,514,000 after buying an additional 89,463 shares during the period. Hedge funds and other institutional investors own 92.72% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.